Monopar Therapeutics (MNPR) › Net IncomeMonopar Therapeutics (MNPR) — Net IncomeAnnual figures by fiscal year, from SEC filings.2016: -$1.19M2017: -$16.55M2018: -$3.23M2019: -$4.22M2020: -$6.30M2021: -$9.10M2022: -$10.52M2023: -$8.40M2024: -$15.59M2025: -$13.72M-$13.72M2016Net Income (USD)2025Fiscal YearNet IncomeChange YoY2025-$13.72M+12.0%2024-$15.59M-85.5%2023-$8.40M+20.1%2022-$10.52M-15.5%2021-$9.10M-44.4%2020-$6.30M-49.2%2019-$4.22M-30.9%2018-$3.23M+80.5%2017-$16.55M-1296.3%2016-$1.19M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share